Llwytho...
Is insulin-like growth factor-1 involved in Parkinson’s disease development?
Parkinson’s disease (PD) is a neurodegenerative disorder that results in the death of dopaminergic neurons within the substantia nigra pars compacta and the reduction in dopaminergic control over striatal output neurons, leading to a movement disorder most commonly characterized by akinesia or brady...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Transl Med |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BioMed Central
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7014772/ https://ncbi.nlm.nih.gov/pubmed/32046737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12967-020-02223-0 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|